Concepts (150)
Concepts are derived automatically from a person's publications.
Concepts are listed by decreasing relevance which is based on many factors, including how many publications the person wrote about that topic, how long ago those publications were written, and how many publications other people have written on that same topic.
Name | Number of Publications
|
Most Recent Publication
|
Publications by All Authors
|
Concept Score
|
Why?
|
---|
Carcinoma, Merkel Cell | 9 | 2024 | 328 | 2.630 |
Why?
|
Skin Neoplasms | 17 | 2024 | 5821 | 1.880 |
Why?
|
Neoplasms, Basal Cell | 2 | 2022 | 31 | 1.000 |
Why?
|
Carcinoma, Squamous Cell | 6 | 2024 | 4026 | 0.750 |
Why?
|
Annexin A2 | 1 | 2021 | 44 | 0.740 |
Why?
|
Ulcer | 1 | 2021 | 204 | 0.680 |
Why?
|
Oncolytic Viruses | 1 | 2023 | 344 | 0.630 |
Why?
|
Carcinoma, Basal Cell | 2 | 2022 | 560 | 0.580 |
Why?
|
Nuclear Physics | 6 | 2014 | 75 | 0.570 |
Why?
|
Drug Approval | 3 | 2022 | 814 | 0.570 |
Why?
|
Oncolytic Virotherapy | 1 | 2023 | 516 | 0.560 |
Why?
|
Cytidine Deaminase | 2 | 2016 | 243 | 0.520 |
Why?
|
Small Molecule Libraries | 1 | 2021 | 733 | 0.500 |
Why?
|
Uracil-DNA Glycosidase | 1 | 2014 | 35 | 0.470 |
Why?
|
Immunotherapy | 7 | 2024 | 4651 | 0.460 |
Why?
|
Adaptor Proteins, Signal Transducing | 2 | 2021 | 2898 | 0.430 |
Why?
|
Uracil | 1 | 2014 | 207 | 0.420 |
Why?
|
Elementary Particles | 4 | 2014 | 52 | 0.400 |
Why?
|
Psoriasis | 1 | 2020 | 950 | 0.390 |
Why?
|
Biological Products | 1 | 2020 | 914 | 0.360 |
Why?
|
Lymphoproliferative Disorders | 1 | 2014 | 531 | 0.360 |
Why?
|
Molecular Targeted Therapy | 1 | 2021 | 2811 | 0.340 |
Why?
|
Head and Neck Neoplasms | 4 | 2024 | 2895 | 0.320 |
Why?
|
Spleen | 1 | 2014 | 2295 | 0.300 |
Why?
|
Melanoma | 2 | 2024 | 5709 | 0.290 |
Why?
|
Models, Theoretical | 7 | 2014 | 3575 | 0.260 |
Why?
|
Transcription Factors | 2 | 2021 | 12130 | 0.230 |
Why?
|
United States Food and Drug Administration | 3 | 2022 | 1664 | 0.230 |
Why?
|
Neutrons | 2 | 2014 | 77 | 0.220 |
Why?
|
Randomized Controlled Trials as Topic | 1 | 2020 | 10212 | 0.210 |
Why?
|
Neoplasm Staging | 5 | 2024 | 11120 | 0.200 |
Why?
|
Neoadjuvant Therapy | 2 | 2024 | 2827 | 0.190 |
Why?
|
Neoplasms, Squamous Cell | 1 | 2021 | 95 | 0.180 |
Why?
|
B-Lymphocytes | 1 | 2014 | 4758 | 0.180 |
Why?
|
Retreatment | 1 | 2021 | 598 | 0.170 |
Why?
|
Cryosurgery | 1 | 2024 | 474 | 0.160 |
Why?
|
Administration, Topical | 1 | 2021 | 704 | 0.160 |
Why?
|
Adult Stem Cells | 1 | 2021 | 221 | 0.160 |
Why?
|
Tumor Burden | 2 | 2021 | 1893 | 0.160 |
Why?
|
Ultraviolet Rays | 1 | 2022 | 1080 | 0.140 |
Why?
|
Molecular Structure | 1 | 2021 | 1880 | 0.140 |
Why?
|
Combined Modality Therapy | 3 | 2024 | 8528 | 0.130 |
Why?
|
DNA Damage | 2 | 2016 | 2449 | 0.120 |
Why?
|
Hydroxylamines | 1 | 2015 | 40 | 0.120 |
Why?
|
Neuralgia | 1 | 2021 | 615 | 0.120 |
Why?
|
Neoplasm Metastasis | 2 | 2024 | 4915 | 0.120 |
Why?
|
Palatine Tonsil | 1 | 2014 | 193 | 0.110 |
Why?
|
Alkynes | 1 | 2015 | 320 | 0.110 |
Why?
|
Humans | 25 | 2024 | 761578 | 0.110 |
Why?
|
Immunologic Factors | 1 | 2022 | 1590 | 0.110 |
Why?
|
Antibodies, Viral | 1 | 2024 | 3156 | 0.100 |
Why?
|
Biopsy | 2 | 2021 | 6766 | 0.100 |
Why?
|
Papillomavirus Infections | 1 | 2024 | 1613 | 0.100 |
Why?
|
Retrospective Studies | 8 | 2024 | 80646 | 0.100 |
Why?
|
Physics | 1 | 2011 | 91 | 0.090 |
Why?
|
Antineoplastic Combined Chemotherapy Protocols | 2 | 2022 | 11742 | 0.090 |
Why?
|
Protons | 2 | 2012 | 1116 | 0.090 |
Why?
|
Genome | 2 | 2016 | 1740 | 0.080 |
Why?
|
High-Throughput Nucleotide Sequencing | 1 | 2021 | 3639 | 0.080 |
Why?
|
Medical Oncology | 1 | 2021 | 2321 | 0.080 |
Why?
|
Dose-Response Relationship, Drug | 1 | 2021 | 10766 | 0.080 |
Why?
|
DNA Replication | 1 | 2016 | 1418 | 0.080 |
Why?
|
Disease Progression | 2 | 2024 | 13510 | 0.080 |
Why?
|
Cell Proliferation | 2 | 2021 | 10451 | 0.080 |
Why?
|
Treatment Outcome | 4 | 2024 | 64684 | 0.070 |
Why?
|
Phosphotransferases (Alcohol Group Acceptor) | 1 | 2009 | 435 | 0.070 |
Why?
|
Diagnostic Imaging | 1 | 2021 | 3530 | 0.070 |
Why?
|
Particle Accelerators | 1 | 2007 | 174 | 0.070 |
Why?
|
Aged | 7 | 2024 | 169308 | 0.070 |
Why?
|
Lipopolysaccharides | 1 | 2014 | 2206 | 0.070 |
Why?
|
DNA Mutational Analysis | 1 | 2015 | 4111 | 0.070 |
Why?
|
United States | 4 | 2022 | 72335 | 0.060 |
Why?
|
Mutagenesis | 1 | 2009 | 1232 | 0.060 |
Why?
|
Aged, 80 and over | 4 | 2024 | 58983 | 0.060 |
Why?
|
Deoxycytidine | 1 | 2009 | 877 | 0.060 |
Why?
|
Drug Resistance, Neoplasm | 1 | 2020 | 5305 | 0.060 |
Why?
|
Prognosis | 2 | 2024 | 29629 | 0.060 |
Why?
|
Research Design | 1 | 2020 | 6180 | 0.060 |
Why?
|
Apoptosis | 1 | 2020 | 9491 | 0.060 |
Why?
|
Gene Expression Regulation, Neoplastic | 1 | 2020 | 8553 | 0.060 |
Why?
|
Photons | 1 | 2007 | 589 | 0.060 |
Why?
|
Nuclear Energy | 2 | 2012 | 15 | 0.050 |
Why?
|
Cell Line, Tumor | 2 | 2020 | 16990 | 0.050 |
Why?
|
Parotid Gland | 1 | 2023 | 175 | 0.050 |
Why?
|
Severity of Illness Index | 1 | 2020 | 15843 | 0.050 |
Why?
|
Polyomavirus Infections | 1 | 2024 | 194 | 0.050 |
Why?
|
Mice, Transgenic | 1 | 2014 | 9542 | 0.050 |
Why?
|
Thermodynamics | 2 | 2014 | 595 | 0.050 |
Why?
|
Tumor Virus Infections | 1 | 2024 | 438 | 0.050 |
Why?
|
Proteins | 1 | 2016 | 6032 | 0.050 |
Why?
|
Interdisciplinary Studies | 1 | 2021 | 86 | 0.040 |
Why?
|
Drosophila melanogaster | 1 | 2009 | 1712 | 0.040 |
Why?
|
Antineoplastic Agents | 2 | 2022 | 13642 | 0.040 |
Why?
|
Middle Aged | 6 | 2024 | 220917 | 0.040 |
Why?
|
Animals | 4 | 2021 | 168475 | 0.040 |
Why?
|
Liver | 1 | 2014 | 7527 | 0.040 |
Why?
|
MAP Kinase Kinase 1 | 1 | 2020 | 332 | 0.040 |
Why?
|
Papillomaviridae | 1 | 2024 | 1119 | 0.040 |
Why?
|
Male | 7 | 2024 | 360841 | 0.040 |
Why?
|
Escherichia coli | 1 | 2009 | 4217 | 0.040 |
Why?
|
DNA, Viral | 1 | 2024 | 2202 | 0.040 |
Why?
|
Mice | 2 | 2021 | 81539 | 0.030 |
Why?
|
Female | 7 | 2024 | 392688 | 0.030 |
Why?
|
Deamination | 1 | 2016 | 25 | 0.030 |
Why?
|
Propensity Score | 1 | 2024 | 1913 | 0.030 |
Why?
|
Cysts | 1 | 2021 | 681 | 0.030 |
Why?
|
Mice, Inbred C57BL | 1 | 2014 | 22173 | 0.030 |
Why?
|
Workflow | 1 | 2021 | 851 | 0.030 |
Why?
|
Methyl Methanesulfonate | 1 | 2015 | 28 | 0.030 |
Why?
|
Lung Neoplasms | 1 | 2020 | 13382 | 0.030 |
Why?
|
DNA-(Apurinic or Apyrimidinic Site) Lyase | 1 | 2015 | 72 | 0.030 |
Why?
|
Mesons | 1 | 2014 | 31 | 0.030 |
Why?
|
Diagnostic Errors | 1 | 2021 | 1265 | 0.030 |
Why?
|
Biotin | 1 | 2015 | 253 | 0.030 |
Why?
|
Neoplasm Invasiveness | 1 | 2021 | 3597 | 0.030 |
Why?
|
Electrons | 1 | 2014 | 265 | 0.030 |
Why?
|
Gene Deletion | 1 | 2020 | 2665 | 0.020 |
Why?
|
Tumor Microenvironment | 1 | 2024 | 3878 | 0.020 |
Why?
|
Cohort Studies | 2 | 2024 | 41493 | 0.020 |
Why?
|
Cytidine | 1 | 2009 | 64 | 0.020 |
Why?
|
Cell Survival | 1 | 2020 | 5791 | 0.020 |
Why?
|
Cell Death | 1 | 2015 | 1679 | 0.020 |
Why?
|
DNA | 2 | 2015 | 7213 | 0.020 |
Why?
|
HeLa Cells | 1 | 2015 | 3094 | 0.020 |
Why?
|
Cell Cycle Proteins | 1 | 2020 | 3449 | 0.020 |
Why?
|
Stress, Physiological | 1 | 2016 | 1403 | 0.020 |
Why?
|
Azacitidine | 1 | 2009 | 336 | 0.020 |
Why?
|
Massachusetts | 1 | 2021 | 8830 | 0.020 |
Why?
|
Skin | 1 | 2021 | 4484 | 0.020 |
Why?
|
Monte Carlo Method | 1 | 2012 | 1258 | 0.020 |
Why?
|
Fluorescence | 1 | 2009 | 756 | 0.020 |
Why?
|
DNA Mismatch Repair | 1 | 2009 | 428 | 0.020 |
Why?
|
Uncertainty | 1 | 2011 | 754 | 0.020 |
Why?
|
Diagnosis, Differential | 1 | 2021 | 12973 | 0.020 |
Why?
|
Transcription, Genetic | 1 | 2020 | 7593 | 0.020 |
Why?
|
Registries | 1 | 2022 | 8224 | 0.020 |
Why?
|
DNA Repair | 1 | 2015 | 2046 | 0.020 |
Why?
|
Mice, Knockout | 1 | 2020 | 14417 | 0.010 |
Why?
|
Microbial Sensitivity Tests | 1 | 2009 | 1936 | 0.010 |
Why?
|
Data Interpretation, Statistical | 1 | 2012 | 2691 | 0.010 |
Why?
|
Cell Line | 1 | 2016 | 15601 | 0.010 |
Why?
|
Sensitivity and Specificity | 1 | 2015 | 14665 | 0.010 |
Why?
|
Phosphorylation | 1 | 2009 | 8321 | 0.010 |
Why?
|
Signal Transduction | 1 | 2020 | 23447 | 0.010 |
Why?
|
DNA Methylation | 1 | 2009 | 4399 | 0.010 |
Why?
|
Mutation | 1 | 2020 | 30054 | 0.010 |
Why?
|
Brain | 1 | 2021 | 27121 | 0.010 |
Why?
|
Magnetic Resonance Imaging | 1 | 2021 | 36426 | 0.010 |
Why?
|
Computer Simulation | 1 | 2007 | 6241 | 0.010 |
Why?
|
Adult | 1 | 2024 | 221200 | 0.010 |
Why?
|
Concepts
(150)
Derived automatically from this person's publications.
Explore
_
Co-Authors
(65)
People in Profiles who have published with this person.
Explore
_
Similar People
(60)
People who share similar concepts with this person.
Explore
_
Same Department
People in same department with this person.
Explore
_